AGP Limited (PSX:AGP)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
191.04
-6.74 (-3.41%)
At close: Mar 6, 2026
Market Cap53.49B +12.2%
Revenue (ttm)27.73B +18.2%
Net Income3.69B +79.0%
EPS13.19 +78.7%
Shares Out280.00M
PE Ratio14.48
Forward PE12.01
Dividend4.00 (2.02%)
Ex-Dividend DateSep 2, 2025
Volume696,327
Average Volume1,055,371
Open193.00
Previous Close197.78
Day's Range190.50 - 199.40
52-Week Range142.00 - 258.67
Beta0.23
RSI36.13
Earnings DateMar 2, 2026

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1989
Employees 2,143
Stock Exchange Pakistan Stock Exchange
Ticker Symbol AGP
Full Company Profile

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.

Financial Statements